Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

  • TG Therapeutics (NASDAQ:TGTX) stock rose 57.5% to $8.13 during Thursday's regular session. Trading volume for TG Therapeutics's stock is 5.1 million as of 12:30 EST. This is 209.1% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion. As per the news, the Q3 earnings report came out today.
  • PetIQ (NASDAQ:PETQ) shares moved upwards by 38.46% to $9.9. Trading volume for this security as of 12:30 EST is 973.5K, which is 157.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $290.1 million. As per the news, the Q3 earnings report came out yesterday.
  • BioLife Solns (NASDAQ:BLFS) shares moved upwards by 36.53% to $23.62. As of 12:30 EST, BioLife Solns's stock is trading at a volume of 611.6K, which is 177.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q3 earnings came out yesterday.
  • ZimVie (NASDAQ:ZIMV) shares moved upwards by 31.33% to $9.64. Trading volume for this security as of 12:30 EST is 493.1K, which is 145.6% of its average full-day volume over the last 100 days. The company's market cap stands at $251.4 million. The company's, Q3 earnings came out yesterday.
  • Invitae (NYSE:NVTA) shares moved upwards by 29.38% to $2.95. As of 12:30 EST, Invitae's stock is trading at a volume of 14.8 million, which is 81.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $716.5 million. As per the news, the Q3 earnings report came out 2 days ago.
  • NanoString Technologies (NASDAQ:NSTG) shares increased by 26.79% to $7.43. Trading volume for NanoString Technologies's stock is 1.4 million as of 12:30 EST. This is 147.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $346.5 million. As per the press release, Q3 earnings came out 3 days ago.

Losers

  • Apyx Medical (NASDAQ:APYX) stock declined by 62.8% to $1.64 during Thursday's regular session. Trading volume for Apyx Medical's stock is 1.8 million as of 12:30 EST. This is 1390.0% of its average full-day volume over the last 100 days. The company's market cap stands at $56.6 million. The company's, Q3 earnings came out today.
  • Brainstorm Cell (NASDAQ:BCLI) shares declined by 43.26% to $1.64. As of 12:30 EST, Brainstorm Cell's stock is trading at a volume of 1.6 million, which is 685.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.8 million.
  • Cano Health (NYSE:CANO) shares fell 32.49% to $2.25. As of 12:30 EST, Cano Health's stock is trading at a volume of 21.7 million, which is 244.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $544.7 million. As per the press release, Q3 earnings came out yesterday.
  • Vigil Neuroscience (NASDAQ:VIGL) shares fell 22.98% to $9.49. The market value of their outstanding shares is at $268.2 million. As per the press release, Q3 earnings came out today.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares fell 19.79% to $1.3. Trading volume for this security as of 12:30 EST is 5.1 million, which is 299.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 million.
  • Organogenesis Hldgs (NASDAQ:ORGO) shares declined by 19.26% to $2.5. As of 12:30 EST, Organogenesis Hldgs's stock is trading at a volume of 1.3 million, which is 140.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $326.5 million. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.